Dr. med. Wolfram Jung

Staff Status

1-12 of 12
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2022 Journal Article | 
    ​ ​Outcomes of second allogeneic stem cell transplantation and anti‐relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis​
    Shumilov, E.; Hasenkamp, J. ; Maulhardt, M.; Mazzeo, P.; Schmidt, N.; Boyadzhiev, H. & Jung, W.  et al.​ (2022) 
    Hematological Oncology40(4) pp. 763​-776​.​ DOI: https://doi.org/10.1002/hon.2995 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma​
    Straka, C.; Salwender, H.; Knop, S.; Vogel, M.; Müller, J. ; Metzner, B. & Langer, C. et al.​ (2021) 
    European Journal of Haematology, art. ejh.13690​.​ DOI: https://doi.org/10.1111/ejh.13690 
    Details  DOI 
  • 2021 Journal Article | 
    ​ ​Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM​
    Bachmann, F.; Schreder, M.; Engelhardt, M.; Langer, C.; Wolleschak, D.; Mügge, L. O. & Dürk, H. et al.​ (2021) 
    Cancers13(6) pp. 1322​.​ DOI: https://doi.org/10.3390/cancers13061322 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials​
    von Tresckow, B.; Kreissl, S.; Goergen, H.; Bröckelmann, P. J; Pabst, T.; Fridrik, M. & Rummel, M. et al.​ (2018) 
    The Lancet Haematology5(10) pp. e462​-e473​.​ DOI: https://doi.org/10.1016/S2352-3026(18)30140-6 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease​
    Wulf, G. ; Hasenkamp, J. ; Jung, W. ; Wilhelm, C.; Held, G.; Nickelsen, M. & Leha, A.  et al.​ (2018) 
    Bone Marrow Transplantation54(6) pp. 877​-884​.​ DOI: https://doi.org/10.1038/s41409-018-0360-9 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Nilotinib (Tasigna®) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)​
    Ottmann, O. G.; Pfeifer, H.; Cayuela, J.-M.; Spiekermann, K.; Jung, W. ; Beck, J. & Raffoux, E. et al.​ (2018) 
    Blood132(Supplement 1) pp. 31​-31​.​ DOI: https://doi.org/10.1182/blood-2018-99-114552 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial​
    Einsele, H.; Engelhardt, M.; Tapprich, C.; Müller, J.; Liebisch, P.; Langer, C. & Kropff, M. et al.​ (2017) 
    British Journal of Haematology179(4) pp. 586​-597​.​ DOI: https://doi.org/10.1111/bjh.14920 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib​
    Shumilov, E.; Wulf, G. ; Ströbel, P. ; Hasenkamp, J. ; Hellige, N.; Bleckmann, A.   & Haase, D.  et al.​ (2016) 
    Leukemia & Lymphoma57(10) pp. 2476​-2480​.​ DOI: https://doi.org/10.3109/10428194.2016.1151510 
    Details  DOI 
  • 2016 Journal Article | 
    ​ ​Combination Immunosuppressive Therapy Including Rituximab for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adult-Onset Still’s Disease​
    Schäfer, E. J.; Jung, W.   & Korsten, P. ​ (2016) 
    Case Reports in Rheumatology2016 pp. 1​-4​.​ DOI: https://doi.org/10.1155/2016/8605274 
    Details  DOI  PMID  PMC 
  • 2010 Journal Article | Research Paper
    ​ ​Implementierung des Querschnittsfachs Palliativmedizin (Q13) vor dem Hintergrund der neuen gesetzlichen Rahmenbedingungen am Bespiel der Universitätsmedizin Göttingen​
    Alt-Epping, B. ; Jung, W. ; Simmenroth-Nadya, A.; Russo, S. G. ; Vormfelde, S. & Nauck, F. ​ (2010) 
    GMS Zeitschrift für medizinische Ausbildung5 pp. 1​-14​.​
  • 2004 Journal Article | Research Paper
    ​ ​Clinical Response Following Adjuvant Temozolomide in a Patient with Primary Cerebral Lymphoma​
    Strik, H. M. ; Spreer, A. ; Nagel, H. ; Jacob, S. ; Jung, W. ; Kitze, B.   & Bähr, M. ​ (2004) 
    Anticancer Research24(6) pp. 4121​-4125​.​
    Details  PMID  PMC  WoS 
  • 2003 Journal Article
    ​ ​A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia​
    Fiedler, W.; Mesters, R.; Tinnefeld, H.; Loges, S.; Staib, P.; Duhrsen, U. & Flasshove, M. et al.​ (2003) 
    Blood102(8) pp. 2763​-2767​.​ DOI: https://doi.org/10.1182/blood-2002-10-2998 
    Details  DOI  PMID  PMC  WoS 

Publication List



Date issued







Citation Style

https://publications.goettingen-research-online.de URI: /cris/rp/rp32516
ID: 0000000
PREF: default TOKEN:



Issue Date




Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.